Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
17views
The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.
from NYT > Top Stories https://ift.tt/waCFcQR
via IFTTT
add a comment